DAWN — DAY ONE BIOPHARMACEUTICALS I

Ownership history in Quarry LP  ·  4 quarters on record

This page tracks every 13F SEC filing in which Quarry LP reported a position in DAY ONE BIOPHARMACEUTICALS I (DAWN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2024 Q1)
Avg. % of fund
0.02%
First filed
2023 Q3
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 7,009 +609 +9.5% 0.01% $49K $7.05
2024 Q1 ADDED 6,400 +1,400 +28.0% 0.02% $106K $16.52
2023 Q4 REDUCED 5,000 -1,519 -23.3% 0.01% $73K $14.60
2023 Q3 INITIATED 6,519 — — 0.02% $80K —
% of Fund (quarterly)    DAWN price (monthly, adj. close)

Other funds also holding DAWN

As of 2025 Q4 — sorted by position size

Atlas Venture Life Science Advisors, LLC 3Y 6.91% AIGH Capital Management LLC 3Y 4.49% DAFNA Capital Management LLC 3Y 7Y 2.16% Lion Point Capital, LP 3Y 7Y 2.03% Vestal Point Capital, LP 1.65% Stonepine Capital Management, LLC 3Y 7Y 1.36% MAK CAPITAL ONE LLC 3Y 7Y 0.85% PERKINS CAPITAL MANAGEMENT INC 3Y 7Y 0.62% Parkman Healthcare Partners LLC 3Y 0.57% ORACLE INVESTMENT MANAGEMENT INC 3Y 7Y 0.55%
← Back to Quarry LP Holdings